These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28857860)

  • 1. Hyperlipidemia and cardiovascular disease with focus on familial hypercholesterolemia.
    Holven KB; Ulven SM; Bogsrud MP
    Curr Opin Lipidol; 2017 Oct; 28(5):445-447. PubMed ID: 28857860
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment of familial hypercholesterolemia and of the dyslipidemias responsible for cardiovascular disease].
    Sampietro T; Licitra R
    G Ital Cardiol; 1999 Feb; 29(2):171-3. PubMed ID: 10088075
    [No Abstract]   [Full Text] [Related]  

  • 3. What matters most in pediatric familial hypercholesterolemia, genotype or phenotype?
    Raal FJ; Stein EA
    J Lipid Res; 2014 May; 55(5):793-5. PubMed ID: 24676341
    [No Abstract]   [Full Text] [Related]  

  • 4. Grand rounds from Rutgers Medical School. Familial hypercholesterolemia.
    Conn HL; Kuo PT; Khachadurian AK; Kostis JB
    Med Times; 1980 Apr; 108(4):112-6, 123-9. PubMed ID: 7360031
    [No Abstract]   [Full Text] [Related]  

  • 5. Difficulties in gauging atherosclerotic cardiovascular disease risk heterogeneity in familial hypercholesterolemia.
    Mizuta MH; Santos RD
    Atherosclerosis; 2022 Oct; 358():57-59. PubMed ID: 36049962
    [No Abstract]   [Full Text] [Related]  

  • 6. [Familial hypercholesterolemia].
    Windler E; Beil FU; Altenburg C; Rinninger F
    Dtsch Med Wochenschr; 2012 Nov; 137(46):2375-9. PubMed ID: 23132157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular Disease, Atherosclerosis and Familial Hypercholesterolemia: From Molecular Mechanisms Causing Pathogenicity to New Therapeutic Approaches.
    Jebari-Benslaiman S; Larrea-Sebal A; Benito-Vicente A; Martín C
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein changes in non-LDL-lipoproteins in familial hypercholesterolemia: implications in cardiovascular disease manifestation and outcome.
    Badimon L; Padró T; Cubedo J
    Curr Opin Lipidol; 2017 Oct; 28(5):427-433. PubMed ID: 28682808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum.
    Rynkiewicz A; Cybulska B; Banach M; Filipiak KJ; Guzik T; Idzior-Waluś B; Imiela J; Jankowski P; Kłosiewicz-Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T
    Pol Arch Med Wewn; 2013; 123(1-2):7-10. PubMed ID: 23449188
    [No Abstract]   [Full Text] [Related]  

  • 10. Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.
    Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
    J Clin Lipidol; 2016; 10(6):1329-1337.e3. PubMed ID: 27919349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral middle ear cholesterol granuloma in familial hypercholesterolemia.
    Masaany M; Siti HS; Nurliza I; Mazita A
    Otolaryngol Head Neck Surg; 2008 Jun; 138(6):803-4. PubMed ID: 18503863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.
    van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 2: Hypercholesterolemia.
    Choluj B; Votruba T
    Acta Univ Carol Med (Praha); 1991; 37(3-4):106-15. PubMed ID: 1845465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply: Sex-related differences in premature cardiovascular disease in familial hypercholesterolemia.
    Agarwala A; Ballantyne C; Goldberg A
    J Clin Lipidol; 2023; 17(2):304-305. PubMed ID: 36965960
    [No Abstract]   [Full Text] [Related]  

  • 15. Familial Hypercholesterolemia: The Most Frequent Cholesterol Metabolism Disorder Caused Disease.
    Benito-Vicente A; Uribe KB; Jebari S; Galicia-Garcia U; Ostolaza H; Martin C
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30388787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter regarding the article Sex-Related Differences in Premature Cardiovascular Disease in Familial Hypercholesterolemia.
    Cordero A; Del Olmo MRF
    J Clin Lipidol; 2023; 17(2):303. PubMed ID: 36965959
    [No Abstract]   [Full Text] [Related]  

  • 17. Identifying familial hypercholesterolemia in acute coronary syndrome.
    Gencer B; Nanchen D
    Curr Opin Lipidol; 2016 Aug; 27(4):375-81. PubMed ID: 27092769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic risk factors in the development of heart disease: familial hypercholesterolemia and hyperhomocysteinemia.
    LaCharity LA
    AACN Clin Issues; 1998 Nov; 9(4):531-8. PubMed ID: 9855863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Familial hypercholesterolemia: clinical aspects].
    Ciarrocchi A; Gaddi A; Rimondi S; Mezzetti M; Scaramuzzino G
    Cardiologia; 1988 Nov; 33(11):1055-60. PubMed ID: 3255492
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combined familial hypercholesterolemia and type III hyperlipoproteinemia].
    Levy Y; Aviram M; Baruch Y; Brook JG
    Harefuah; 1984 Jun; 106(12):565-6. PubMed ID: 6479724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.